European Commission and Directorate-General for Competition 23 February 2016, Commission Decision of 23/02/2016 declaring a concentration to be compatible with the common market (Case No COMP/M.7813 - SANOFI / GOOGLE / DMI JV) according to Council Regulation (EC) No 139/2004 (Only the English text is authentic)

Also known as

The European Commission's decision regarding Case M. 7813 involves the proposed joint venture (JV) between Sanofi and Google to manage diabetes treatment through an integrated digital e-medicine platform. The core legal dispute centers on whether the concentration of control over the JV raises competition concerns in relevant markets, including insulins, insulin delivery systems, and glucose monitoring systems. The Commission concluded that the transaction does not raise serious doubts about its compatibility with the internal market, allowing the JV to operate as a full-function entity while addressing potential data privacy and security issues.AI